At 6.8% CAGR, the North America Airway Management Devices Market is projected to be worth US$ 1,496.37 million by 2028, says Business Market Insights   

According to Business Market Insights’ research, the North America airway management devices market was valued at US$ 1,007.68 million in 2022 and is expected to reach US$ 1,496.37 million by 2028, registering a CAGR of 6.8% from 2022 to 2028. Rising prevalence of respiratory disorders and new product launches and approvals are the critical factors attributed to the market expansion.                 

Chronic respiratory diseases are among the most prevalent noncommunicable diseases worldwide due to the increase in the noxious environment and occupational and behavioral inhalation. This spectrum of diseases includes chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, pulmonary sarcoidosis, and pneumoconiosis (such as silicosis and asbestosis). According to the World Health Organization (WHO), COPD is the third leading cause of death. As per the Office of Disease Prevention and Health Promotion, ~14.8 million adults in the US were diagnosed with COPD in 2020. As per the WHO report, in 2019, asthma resulted in 439,000 hospitalizations and an estimated 1.3 million visits every year in the US. The rising prevalence of respiratory disorders is driving the demand for airway management devices. Additionally, there is a constant surge in the number of hospitals, ambulatory surgical centers, intensive care units, and clinics, creating demand for airway management devices. For instance, according to the American Hospital Association report, there were a total of 6,093 hospitals in the US, including community hospitals, non-federal psychiatric hospitals, and federal government hospitals. Furthermore, various organizations and government bodies are collaborating to increase awareness among a large population and manage chronic disorders. Government authorities and healthcare institutions are implementing various programs to increase asthma awareness to prevent morbidity from the disease. The National Asthma Control Program (NACP), launched by the Centers for Disease Control and Prevention (CDC), is working continually to increase awareness regarding asthma. The program is dedicated to conducting asthma surveillance and research to deal with the disease. Additionally, Airway Collaborative is an education program designed to provide medical professionals with knowledge about incorporating airway treatment into practice and healing airway dysfunctions. Thus, the factors mentioned above are driving the airway management devices market.

On the contrary, rise in product recalls and lack of reimbursement policies hurdles the growth of North America airway management devices market.   

Based on product, the North America airway management devices market is segmented into infraglottic devices, supraglottic devices, laryngoscopes, resuscitators, and others. The infraglottic devices segment held 37.4% market share in 2022, amassing US$ 376.92 million. It is projected to garner US$ 556.86 million by 2028 to expand at 6.7% CAGR during 2022–2028.

Based on end user, the North America airway management devices market is categorized into hospitals, ambulatory surgical care centers, and others. The hospitals segment held 75.2% market share in 2022, amassing US$ 757.63 million. It is projected to garner US$ 1,122.81 million by 2028 to expand at 6.8% CAGR during 2022–2028.

Based on country, the North America airway management devices market has been segmented into the US, Canada, and Mexico.  Our regional analysis states that the US captured 90.5% market share in 2022. It was assessed at US$ 911.85 million in 2022 and is likely to hit US$ 1,353.47 million by 2028, exhibiting a CAGR of 6.8% during the forecast period.  

Key players dominating the North America airway management devices market are Teleflex Incorporated; Smiths Medical; Medtronic; Intersurgical Ltd; Ambu A/S; Medline Industries, Inc.; Koninklijke Philips N.V.; ARMSTRONG MEDICAL; Mercury Medical; and Cook Medical LLC, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com